Literature DB >> 15579729

Pulmonary manifestations of primary Sjogren's syndrome: a clinical, radiologic, and pathologic study.

Isao Ito1, Sonoko Nagai, Masanori Kitaichi, Andrew G Nicholson, Takeshi Johkoh, Satoshi Noma, Dong Soon Kim, Tomohiro Handa, Takateru Izumi, Michiaki Mishima.   

Abstract

RATIONALE: Clinicopathologic pulmonary manifestations associated with primary Sjogren's syndrome have yet to be reviewed in a large series since the recognition of nonspecific interstitial pneumonia (NSIP) as a distinct histologic pattern.
OBJECTIVES: To determine clinical presentations, high-resolution computed tomographic (HRCT) and histologic findings of the lung disease associated with primary Sjogren's syndrome in the light of NSIP, and to analyze prognosis of the disease.
METHODS: On the basis of 33 cases (31 surgical lung biopsies and 2 autopsies) collected consecutively from multiple centers, we have retrospectively evaluated clinical, radiologic, and pathologic manifestations of the disease. Prognostic factors were identified by univariate and multivariate analysis.
MEASUREMENTS AND MAIN RESULTS: We found that NSIP was the most frequently seen histologic pattern (20 of 33 cases [61%], 19 fibrosing and 1 cellular). Bronchiolar diseases and amyloid and malignant lymphoma were seen less frequently. HRCT-pathologic correlation resulted in a 94% positive predictive value of CT-NSIP pattern for pathologic diagnosis of NSIP, whereas the diagnostic value of HRCT was low (15%) with an HRCT pattern other than NSIP, data that may influence the decision to biopsy. The 5-year survival rate was 84% overall and 83% in patients with NSIP. Multivariate analysis on all patients showed that low Pa(O(2)) (p = 0.02) and presence of microscopic honeycombing (p = 0.04) were independently associated with survival. Patients with NSIP showed lower vital capacity (mean +/- SD: 68.5 +/- 16.6%pred) than patients without NSIP (92.5 +/- 18.6%pred; p < 0.001).
CONCLUSION: Among a diversity of pulmonary lesions in primary Sjogren's syndrome, NSIP was the commonest histologic pattern and had a favorable prognosis.

Entities:  

Mesh:

Year:  2004        PMID: 15579729     DOI: 10.1164/rccm.200403-417OC

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  59 in total

1.  Pulmonary manifestations of systemic autoimmune diseases.

Authors:  Manole Cojocaru; Inimioara Mihaela Cojocaru; Isabela Silosi; Camelia Doina Vrabie
Journal:  Maedica (Bucur)       Date:  2011-07

2.  Organizing pneumonia associated with Sjogren's syndrome: a comment.

Authors:  Sheng-Yuan Ruan; Yao-Wen Kuo
Journal:  Rheumatol Int       Date:  2008-11-07       Impact factor: 2.631

Review 3.  Sjögren's syndrome accompanied with interstitial cystitis: a case report and review of the literature.

Authors:  Dongfeng Liang; Jinshan Lu; Aitao Guo
Journal:  Clin Rheumatol       Date:  2014-01-07       Impact factor: 2.980

4.  Pirfenidone for primary Sjögren's syndrome-related fibrotic interstitial pneumonia.

Authors:  Yasunori Enomoto; Yutaro Nakamura; Thomas V Colby; Naoki Inui; Takafumi Suda
Journal:  Sarcoidosis Vasc Diffuse Lung Dis       Date:  2017-04-28       Impact factor: 0.670

Review 5.  Management of interstitial lung disease associated with connective tissue disease.

Authors:  Stephen C Mathai; Sonye K Danoff
Journal:  BMJ       Date:  2016-02-24

6.  Survival analysis of patients with Sjögren's syndrome in Turkey: a tertiary hospital-based study.

Authors:  Veli Yazisiz; Mesut Göçer; Funda Erbasan; İsmail Uçar; Bengisu Aslan; Şuayp Oygen; Edip Gökalp Gök; Mustafa Ender Terzioğlu
Journal:  Clin Rheumatol       Date:  2019-09-25       Impact factor: 2.980

7.  Cryptogenic organizing pneumonia associated with primary Sjogren's syndrome.

Authors:  Savvas Ioannou; Sophie P Toya; Periklis Tomos; George E Tzelepis
Journal:  Rheumatol Int       Date:  2008-04-01       Impact factor: 2.631

8.  Lung involvement in patients with primary Sjögren's syndrome: what are the predictors?

Authors:  Veli Yazisiz; Gokhan Arslan; Irem Hicran Ozbudak; Sema Turker; Funda Erbasan; Ali Berkant Avci; Omer Ozbudak; Ender Terzioglu
Journal:  Rheumatol Int       Date:  2009-10-21       Impact factor: 2.631

Review 9.  Interstitial lung disease in systemic sclerosis.

Authors:  Predrag Ostojic; Marco Matucci Cerinic; Richard Silver; Kristin Highland; Nemanja Damjanov
Journal:  Lung       Date:  2007 Jul-Aug       Impact factor: 2.584

Review 10.  Interstitial lung disease in connective tissue diseases: evolving concepts of pathogenesis and management.

Authors:  Flavia V Castelino; John Varga
Journal:  Arthritis Res Ther       Date:  2010-08-23       Impact factor: 5.156

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.